how were glp 1 agonists discovered GLP-1 Receptor Evolved from Diabetes to Weight Loss Treatments History of glucagon-like peptide-1 receptor

The alarming worldwide increase in obesity requires the development of new molecules that increase patient compliance by reducing the frequency of administration, facilitating intake, and reducing the adverse effects of treatments

t hiu qu r rt hn, c bit l ci thin sc t, c th cn 3 6 thng hoc lu hn, ty c a v tnh trng da ban u

38,39,40 The phenotype observed after GLP-1R knockout (KO) includes various physiological and metabolic changes

Consistent with this, in a similar study in the SOD1 G93A mouse model, treatment with MitoQ at the onset of disease also delayed the decline of mitochondrial function in the spinal cord, protected against motor neuron loss and astrogliosis in the spinal cord